Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2002-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioequivalence of a test
clarithromycin extended release formulation to an equivalent oral dose of the commercially
available extended release clarithromycin in a test population of 66 adult subjects under
fasting conditions.